BNP Paribas Financial Markets’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,757
| Closed | -$104K | – | 3577 |
|
|
2020
Q3 | $104K | Buy |
5,757
+2,427
| +73% | +$44K | ﹤0.01% | 2480 |
|
|
2020
Q2 | $45.6K | Sell |
3,330
-4,562
| -58% | -$62.5K | ﹤0.01% | 2447 |
|
|
2020
Q1 | $113K | Buy |
7,892
+5,957
| +308% | +$85.2K | ﹤0.01% | 2540 |
|
|
2019
Q4 | $32.8K | Sell |
1,935
-672
| -26% | -$11.4K | ﹤0.01% | 3188 |
|
|
2019
Q3 | $40.1K | Buy |
2,607
+616
| +31% | +$9.48K | ﹤0.01% | 2969 |
|
|
2019
Q2 | $46.7K | Sell |
1,991
-1,174
| -37% | -$27.5K | ﹤0.01% | 2843 |
|
|
2019
Q1 | $89.7K | Buy |
3,165
+2,829
| +842% | +$80.1K | ﹤0.01% | 2602 |
|
|
2018
Q4 | $10.1K | Sell |
336
-405
| -55% | -$12.2K | ﹤0.01% | 2672 |
|
|
2018
Q3 | $26K | Buy |
741
+56
| +8% | +$1.96K | ﹤0.01% | 2648 |
|
|
2018
Q2 | $16.2K | Sell |
685
-2,748
| -80% | -$65.2K | ﹤0.01% | 2929 |
|
|
2018
Q1 | $87.9K | Buy |
3,433
+60
| +2% | +$1.54K | ﹤0.01% | 2680 |
|
|
2017
Q4 | $58.6K | Buy |
3,373
+2,479
| +277% | +$43K | ﹤0.01% | 2919 |
|
|
2017
Q3 | $24.7K | Buy |
+894
| New | +$24.7K | ﹤0.01% | 2985 |
|